J&J Blasts 'Tainted Process' In Imerys Ch. 11 Case

Law360 (March 3, 2021, 8:01 PM EST) -- Johnson & Johnson has told a Delaware bankruptcy court that talc supplier Imerys Talc America is engaging in unfair Chapter 11 maneuvers aimed at shielding its parent company from liability for talcum powder cancer claims and saddling the pharmaceutical giant with the bill.

In challenging what it called "a tainted process marked by a glaring moral hazard," J&J told the court Tuesday that Imerys shouldn't benefit from indemnity agreements between the companies after having ceded control over settlement procedures and values to cancer victims' representatives in exchange for protecting parent Imerys Group.

That "collusive deal" has led to a proposed Chapter...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!